Lee, M. (2020) Studies of Empagliflozin and its Cardiovascular, Renal and Metabolic Effects in Patients With Diabetes Mellitus (or Prediabetes) and Heart Failure: a Randomized Controlled Trial (SUGAR-DM-HF). American Heart Association’s Scientific Sessions 2020, 13-17 Nov 2020. e484. (doi: 10.1161/CIR.0000000000000940)
Full text not currently available from Enlighten.
Abstract
No abstract available.
| Item Type: | Conference or Workshop Item |
|---|---|
| Additional Information: | Conference abstract published in Circulation 142(24): e484. |
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Lee, Matthew |
| Authors: | Lee, M. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
| ISSN: | 0009-7322 |
| Published Online: | 14 December 2020 |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details